Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Orphazyme A/S - American Depositary Shares (NQ: ORPH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orphazyme A/S - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
32 Stocks Moving in Thursday's Pre-Market Session
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 40... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5... 
Via Benzinga
Orphazyme Tightens FY21 Revenue Outlook
Orphazyme A/S (NASDAQ: ORPH) expects FY21 sales of DKK 35 million – DKK 37 million, compared to the previous guidance of DKK 30 million – DKK 40 million. It... 
Via Benzinga
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday. 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
23 Stocks Moving in Friday's Pre-Market Session
Gainers Modular Medical Inc (NASDAQ: MODD) rose 321% to $15.64 in pre-market trading. Modular Medical, on Thursday, reported pricing of $15 million public offering... 
Via Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)... 
Via Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug... 
Via Benzinga
Exposures COVID-19 Product Safety
64 Biggest Movers From Yesterday
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... 
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the... 
Via Benzinga
Orphazyme Stock Gains After FDA Update On Arimoclomol In Rare Neurodegenerative Disorder
Orphazyme A/S (NASDAQ: ORPH) shares are moving higher after providing a regulatory update for arimoclomol in Niemann-Pick disease type C (NPC). The Company had a... 
Via Benzinga
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, investor! We're starting off the trading week with a breakdown of the biggest pre-market stock movers for Monday! 
Via InvestorPlace
28 Stocks Moving in Monday's Pre-Market Session
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 333.9% to $11.02 in pre-market trading. ABVC Biopharma’s S-3 showed registration for $50 million mixed securities shelf... 
Via Benzinga
44 Biggest Movers From Yesterday
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after... 
Via Benzinga
Promising New Developments Causing Some Biotech Stocks to Pull Away from Underperforming Peers
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 14, 2021 – USA News Group – Compared to the Dow Jones Industrial Average which has gained an impressive 10.6% through Q3... 
Via FinancialNewsMedia
Topics Stocks
Exposures US Equities
ORPH Stock Alert: What’s Going on With Red-Hot Orphazyme Today?
Today, retail investors and traders appear willing to put some big money down on Orphazyme and ORPH stock as a potential short-squeeze play. 
Via InvestorPlace
50 Biggest Movers From Yesterday
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating... 
Via Benzinga
Orphazyme A/S (NASDAQ:ORPH) Shareholder Notice: Deadline in Lawsuit on September 7, 2021
San Diego, CA -- (SBWIRE) -- 10/06/2021 -- The Shareholders Foundation announced that a deadline is coming up on September 7, 2021 in the lawsuit filed for certain investors of Orphazyme A/S... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal Product Safety
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... 
Via Benzinga
Final Deadline for Investors with Losses Exceeding $500K to Actively Participate in the Orphazyme A/S (ORPH) Class Action - Bronstein, Gewirtz & Grossman, LLC
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)
From The Law Offices of Frank R. Cruz
Via Business Wire
TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.